Chinese Reverse Merger Co. Hyped 'Worthless' Stock: Suit
An investor hit Chinese drugmaker Jiangbo Pharmaceuticals Inc., which went public via reverse merger in 2007, with a proposed class action in Florida on Tuesday claiming its executives crowed about its...To view the full article, register now.
Already a subscriber? Click here to view full article